Literature DB >> 11529881

Modulation of the expression of the Cip/Kip family of cyclin-dependent kinase inhibitors in foetal developing lungs of hamsters.

T Ikoma1, T Ito, K Okudela, H Hayashi, T Yazawa, H Kitamura.   

Abstract

We examine the cell proliferation activity and expression of cyclin-dependent kinase inhibitors of the Cip/Kip family, p21Cip1, p27Kip1 and p57Kip2, in foetal hamster lungs to determine the expression patterns of the cyclin-dependent kinase inhibitors and to clarify the relationship between expression of the cyclin-dependent kinase inhibitors and lung development. Foetal hamster lungs on gestational days 12.5-16 (the day of birth) and adult lungs were fixed in 4% paraformaldehyde. Frozen sections were immunostained for the cyclin-dependent kinase inhibitors, and examined by immunostaining for Ki-67 and bromodeoxyuridine to determine the proliferation activity of the foetal lungs. During the foetal period, cell proliferation activity, as analysed by Ki-67 or bromodeoxyuridine labelling, decreased with development of the lung. In contrast to the gradual decrease of cell proliferation activity, cells with p27Kip1 immunoreactivity increased with development. On the other hand, p21Cip1-positive cells were most prominent around gestational day 14.5, while after birth positive cells decreased markedly. A few p57Kip2-positive cells were detected in the bronchiolar epithelium on gestational day 14.5. Western blotting analyses confirmed these immunostaining patterns. Thus, the levels of the cyclin-dependent kinase inhibitors of the Cip/Kip family are modulated in the lungs during the foetal period, and each shows a unique expression pattern. The cyclin-dependent kinase inhibitors may play roles not only in regulating cell proliferation activity but also in regulating other functions such as differentiation in the lung during the foetal period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529881      PMCID: PMC6496879          DOI: 10.1046/j.0960-7722.2001.00209.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  23 in total

Review 1.  Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development.

Authors:  K Nakayama; K Nakayama
Journal:  Bioessays       Date:  1998-12       Impact factor: 4.345

Review 2.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.

Authors:  J Q Tian; A Quaroni
Journal:  Am J Physiol       Date:  1999-06

4.  p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.

Authors:  Y Yatabe; A Masuda; T Koshikawa; S Nakamura; T Kuroishi; H Osada; T Takahashi; T Mitsudomi; T Takahashi
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

5.  Changes in glycoconjugates revealed by lectin staining in the developing airways of Syrian golden hamsters.

Authors:  T Ito; C Newkirk; J M Strum; E M McDowell
Journal:  Anat Rec       Date:  1990-10

Review 6.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

Authors:  R V Lloyd; L A Erickson; L Jin; E Kulig; X Qian; J C Cheville; B W Scheithauer
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine.

Authors:  K Okudela; T Ito; H Mitsui; H Hayashi; N Udaka; M Kanisawa; H Kitamura
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step.

Authors:  P Zhang; C Wong; D Liu; M Finegold; J W Harper; S J Elledge
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

9.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Authors:  S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

10.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

Authors:  M B Datto; Y Li; J F Panus; D J Howe; Y Xiong; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  1 in total

Review 1.  The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.

Authors:  Kay-Dietrich Wagner; Nicole Wagner
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.